Salient Surgical Technologies Reaches Key Milestone of 500,000 Patients Treated With TRANSCOLLATION(R) Technology

Published: Nov 03, 2010

PORTSMOUTH, N.H.--(BUSINESS WIRE)--Salient Surgical Technologies, Inc., has announced the achievement of a key milestone in the company’s history – treatment of the 500,000th patient using its patented TRANSCOLLATION technology, which enables surgeons to stop intra-operative bleeding during their procedures and reduce blood loss for patients following surgery.

Back to news